Intrinsiqs

Is Immix Biopharma, Inc. overvalued?

Immix Biopharma, Inc. (IMMX) — key valuation metrics and fundamentals.

No verdict
Price
$10.64
Fair value
Current P/E
Normal P/E
Market cap
$583.2M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares IMMX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.